InnoCan Pharma Corporation (IP40)
Munich
Real-time Data
06:00 AM
Day's Range
1.2652 wk Range
1.26Overview - IP40 - InnoCan Pharma Corporation
Key Statistics
Valuation
P/E (Trailing)
‪-4.88‬
PEG Ratio
‪0.05‬
Price / Book
‪0.74‬
Profitability
Gross Margin
‪90.83%‬
Profit Margin
‪89.92%‬
Operating Margin
‪0.33%‬
Return on Assets
‪-10.68%‬
Return on Equity
‪-13.64%‬
Ownership
Shares Outstanding
4.49M
Price stats
50-Day Avg
‪1.43‬
200-Day Avg
‪2.97‬
Peers - IP40 - InnoCan Pharma Corporation
Peer Comparison
Compared with companies in Household & Personal Products listed on Munich.
- IP40MunichInnoCan Pharma Corporation-734.43%52-week change-4.88P/E (Trailing)‪89.92%‬Profit Margin
- 1PGMunichAker BioMarine ASA+32.00%52-week change162.67P/E (Trailing)‪-5.85%‬Profit Margin
- 8UAMunichRevolution Beauty Group plc+46.85%52-week change-0.99P/E (Trailing)‪36.88%‬Profit Margin
- 10WMunichMcBride plc+34.91%52-week change—P/E (Trailing)—Profit Margin
- KOYMunichKobayashi Pharmaceutical Co., Ltd.+32.35%52-week change0.83P/E (Trailing)‪51.11%‬Profit Margin
- APOMunichCleango Innovations Inc.+30.77%52-week change-3.39P/E (Trailing)‪38.33%‬Profit Margin
- HT2MunichHelen of Troy Limited+29.24%52-week change-0.61P/E (Trailing)‪45.66%‬Profit Margin
Profile Summary - IP40 - InnoCan Pharma Corporation
About
InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (CBD) with other pharmaceutical ingredients to treat chronic pain, epilepsy, and other medical conditions. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
